About Mesoblast - ADR (MESO)
Mesoblast Limited is engaged in the development of regenerative medicine products. The Company’s regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells. Its allogeneic, off-the-shelf cell... Read more
- USD11.00
- USD11.06
- USD10.41
- 437.95k
Stock News
4 hours ago
Dow Jones Futures Fall, Oil Climbs After U.S. Bombs Iran Nuclear Sites; Tesla Launches Robotaxi Service
Yahoo
4 hours ago
U.S. Strikes On Iran Intensify Oil Supply Risks
SeekingAlpha
yesterday
It isn’t just the Strait of Hormuz. Oil traders and global investors await Iran’s response to U.S. strike.
MarketWatch
yesterday
It's A Yield Trap: Don't Get Stranded On Orchid Island Capital
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
